Koyfin Home > Directory > Health Care > Lannett Co. Inc

Lannett Co. Inc Price Chart LCI

Historical daily share price chart and data for Lannett Co. Inc since 1997 adjusted for splits and dividends. The latest closing price for Lannett Co. Inc as of December 10, 2019 is $8.86.
  • In 2019 the stock opened at $4.89 and closed at $8.86 for a gain of 45% YTD.
  • In 2018 the stock opened at $23.20 and closed at $4.96 for a loss of -368%.
  • In 2017 the stock opened at $22.10 and closed at $23.20 for a gain of 5%.
  • In 2016 the stock opened at $39.51 and closed at $22.05 for a loss of -79%.
View Chart On Koyfin

Lannett Co. Inc Summary

Stock Symbol: LCI

Lannett Co. Inc Company Info

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as antibiotic, anti-psychosis, cardiovascular, central nervous system, gallstone, gastrointestinal, glaucoma, migraine, muscle relaxant, pain management, respiratory, thyroid deficiency, urinary, and others medical indications. The company’s primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Verapamil SR tablets, Ursodiol capsules, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Dicyclomine tablets and capsules, Metolazone tablets, and Methylphenidate Hydrochloride ER, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Market Cap
347.5m
Dividend Yield
0 %
Beta vs SPX
1.66
Short Interest
1567.53 %
30D Volatility
42.5
Hedge Fund Held
0 %
Competitors

Last 10 Days of LCI Prices

12/10/2019$8.86
12/09/2019$9.18
12/06/2019$8.80
12/05/2019$8.49
12/04/2019$8.65
12/03/2019$8.86
12/02/2019$8.74
11/29/2019$8.82
11/27/2019$8.91
11/26/2019$8.89